Controlled release products offer improved safety and performance. Explore the benefits of transdermal and chewable gum based bioactive delivery.

EXPLORE THE BENEFITS

Products tailored to your clients’ needs

Controlled release products offer safe, gentle, sustained, and predictable performance. Transdermal and chewable gum products can be tailored to your needs and offer end users improved user experience and safety.

BRAND EXTENSION AND NEW REVENUE STREAMS

We have an experienced team and can bring new bioactive products and revenue streams to our partners. Products can be designed to specific markets, territories and clients. We can deliver cost-effective product development, from product design and field testing through manufacturing set-up. Explore the differences and benefits of chewable gums and transdermals.

REGULATORY COMPLIANT AND TURNKEY PRODUCTION SOLUTIONS

We will help you define the right products for your market and regulatory standards.

INDUSTRY PROVEN TRANSDERMAL TEAM

Zephyrious is a group of industry-tested experts with decades of experience in the development and manufacturing of innovative medical products. Dr. David Enscore, our Chief Technical Officer, is one of the innovators in the basic technology of transdermal drug delivery. He has unique experience in formulating, developing and manufacturing products for controlled and sustained release of a wide range of substances. The Zephyrious team brings expertise in pharmacology, regulatory affairs, efficient clinical testing strategies, chemistry and product development to the rapidly developing field of controlled delivery products.

Controlled Release technology offers improved user experiences in both medicinal and consumer products.

June 28, 2019 in News

Zephyrious acquires manufacturing automation leader Opus Automation accelerating new controlled release product development.

Manufacturing and packaging automation leader Opus has been acquired by Zephyrious.
Read More